Funds hit jackpot in $2b UK biotech deal
SYDNEY: Swiss pharmaceutical giant Novartis has agreed to pay more than $2 billion for early-stage
SYDNEY: Swiss pharmaceutical giant Novartis has agreed to pay more than $2 billion for early-stage
FEATURED
People with mild ADHD and anxiety should not get benefits says MP
100,000 get benefits for ADHD with no need to work
Six signs you’re in the chronic stress danger zone
Chronic conditions start to reshape insurers claims profile
21-year-old with autism defies odds with paid job
BorderPlus maps out global expansion with training-first healthcare mobility model